Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Baumgartner

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Schweizerische Medizinische Wochenschrift|March 22, 1997
Sepsis and septic shockG Zanetti, J D Baumgartner, M P Glauser
Current Clinical Topics in Infectious Diseases|January 1, 1992
Management of septic shock: new approachesJ D Baumgartner, P Eggimann, M P Glauser
Bone Marrow Transplantation|November 1, 1991
Anti-endotoxin antibody for prevention of acute GVHDK Bayston, J D Baumgartner, P Clark, et al.
The Journal of Infectious Diseases|August 1, 1989
Interpretation of data regarding the protection afforded by serum, IgG, or IgM antibodies after immunization with the rough mutant R595 of Salmonella minnesotaJ D Baumgartner, M M Wu, M P Glauser
Schweizerische Medizinische Wochenschrift|January 2, 2001
[Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]P Delarive, J D Baumgartner, M P Glauser, et al.
Lancet (London, England)|September 21, 1991
Septic shock: pathogenesisM P Glauser, G Zanetti, J D Baumgartner, et al.
The Journal of Infectious Diseases|April 1, 1991
Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5J D Baumgartner, D Heumann, T Calandra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1994
Pathogenesis and potential strategies for prevention and treatment of septic shock: an updateM P Glauser, D Heumann, J D Baumgartner, et al.
The Journal of Infectious Diseases|April 1, 1991
Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharidesD Heumann, J D Baumgartner, H Jacot-Guillarmod, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 18, 2001
Breakthrough Streptococcus pneumoniae meningitis during clarithromycin therapy for acute otitis mediaP Y Bochud, T Calandra, P Moreillon, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Schweizerische Medizinische Wochenschrift|March 22, 1997
Sepsis and septic shockG Zanetti, J D Baumgartner, M P Glauser
Current Clinical Topics in Infectious Diseases|January 1, 1992
Management of septic shock: new approachesJ D Baumgartner, P Eggimann, M P Glauser
Bone Marrow Transplantation|November 1, 1991
Anti-endotoxin antibody for prevention of acute GVHDK Bayston, J D Baumgartner, P Clark, et al.
The Journal of Infectious Diseases|August 1, 1989
Interpretation of data regarding the protection afforded by serum, IgG, or IgM antibodies after immunization with the rough mutant R595 of Salmonella minnesotaJ D Baumgartner, M M Wu, M P Glauser
Schweizerische Medizinische Wochenschrift|January 2, 2001
[Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]P Delarive, J D Baumgartner, M P Glauser, et al.
Lancet (London, England)|September 21, 1991
Septic shock: pathogenesisM P Glauser, G Zanetti, J D Baumgartner, et al.
The Journal of Infectious Diseases|April 1, 1991
Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5J D Baumgartner, D Heumann, T Calandra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1994
Pathogenesis and potential strategies for prevention and treatment of septic shock: an updateM P Glauser, D Heumann, J D Baumgartner, et al.
The Journal of Infectious Diseases|April 1, 1991
Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharidesD Heumann, J D Baumgartner, H Jacot-Guillarmod, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 18, 2001
Breakthrough Streptococcus pneumoniae meningitis during clarithromycin therapy for acute otitis mediaP Y Bochud, T Calandra, P Moreillon, et al.
Pageof 6